Role of structural and functional proteins of SARS -COV-2
DOI:
https://doi.org/10.30574/gscbps.2020.12.3.0275Keywords:
SARS COV-2, Structural Proteins, Functional Proteins, Open Reading Frames, Therapeutic TargetAbstract
Severe acute respiratory corona virus-2 (SARS-CoV-2) is a ribonucleic acid (RNA) virus with enveloped no-segmented positive sense belonging to a beta (β) - corona virus family. It has 29,903 nucleotides sized genome with 10 open reading frames (ORF). ORF1 (ab) encodes two polypeptides pp1a and pp1b cleaved into 16 functional proteins, which are mainly intended to form replication transcription complex (RTC). The cleavage process of pp1a and pp1b polypeptides to 16 functional proteins of SARs-CoV-2 is mainly facilitated by main protease and papain-like protease. The replication transcription complex (RTC) formed by the action of 16-functional proteins of SARs-CoV-2 is mainly involved as viral RNA synthesis machinery in the transcriptional and replication process of viral RNAs. ORF (2-10) encodes for structural (for example: spike (S), membrane (M), nucleocapsid (N), and envelop (E)) and accessory proteins of SARs-CoV-2. The main functions of structural proteins are viral assembly, viral coating, viral entry into host cells and assembly of the RNA genome. Accessory proteins are proteins that are not involved in the viral synthesis machinery, as 16 functional proteins, and in the viral assembly, coating, entry into host cells and packaging of Viral RNAs, as structural proteins. Rather, these are proteins that may play central role by enhancing viral assembly process, virulence and pathogenesis of SARs-CoV-2. Our aim in the current review was to elaborate the specific role of these structural and functional proteins on viral genomic replication and transcription, viral assembly, host cell attachment and pathogenesis. Multiple literatures have been reviewed to achieve the objective of this review.
Metrics
References
Wick BG. Coronavirus 2020 what is really happening and how to prevent it. 2020.
Family H. Novel Coronavirus Manual:A Compilation of Things to Know and Do to Protect Yourself from the Wuhan Coronavirus Outbreak. United States by HaLaDi Fam. 2020; 1–52.
Makino S. Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression. Virus Res. 2014;1–12.
Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020; 5(March).
McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19). UpToDate Terms Use. 2020.
Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7:1–10.
Tok TT, Tatar G. Structures and Functions of Coronavirus Proteins : Molecular Modeling of Viral Nucleoprotein -. Int J Virol Infect Dis. 2 june 2017; 1–7.
Tatar G, Tok TT. Structures and Functions of Coronavirus Proteins : Molecular Modeling of Viral Nucleoprotein -. Int J Virol Infect Dis. 1 june 2017 1; 001–001.
Staup AJ, Silva IU De, Catt JT, Tan X, Hammond RG, Johnson MA. Structure of the SARS-Unique Domain C From the Bat Coronavirus HKU4. sagepub. 2019; 1–11.
Sutton G, Fry E, Carter L, Sainsbury S, Walter T, Nettleship J, et al. The nsp9 Replicase Protein of SARS-Coronavirus , Structure and Functional Insights. 2004; 12: 341–353.
Chen Y, Chen Y, Liu Q, Guo D. Emerging coronaviruses : Genome structure, replication and pathogenesis. Med Virol WILEY. January 2020.
Du L, He Y, Zhou Y, Liu S, Zheng BJ. The spike protein of SARS-CoV — a target for vaccine and therapeutic development. Nature. 7 March 2009; 226–36.
Xu J, Zhao S, Teng T, Elgaili , Abualgasim Abdalla Zhu W, Xie L, Wang Y, et al. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. 2020; 12:1–17.
Liao Y, Wei W, Cheung WY, Li W, Li L, Leung GM, et al. Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature. 2020; 1–5.
Mers-Cov. The proximal origin of SARS-CoV-2. Nat Med. 26 April 2020; 450–52.
He J, Tao H, Yan Y, Huang S, Xiao Y. Molecular Mechanism of Evolution and Human infection with SARS-Cov-2. 2020
Terms U, Province H. Corona virus disease 2019 (COVID-19). Up-to-date Terms Use. 2020; 1–32.
Law AHY, Lee DCW, Cheung BKW, Yim HCH, Lau ASY. Role for Nonstructural Protein 1 of Severe Acute Respiratory Syndrome Corona virus in Chemokine Dysregulation. 2007; 81(1):416–22.
Tang X, Li G, Vasilakis N, Zhang Y. Differential Stepwise Evolution of SARS Coronavirus Functional Proteins in Different Host Species. BMC Evol Biol. April 2009; 1–15.
Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, et al. The M , E , and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly , Trafficking , and Release of Virus-Like Particles ᰔ†. Am Soc Microbiol. 2008; 82(22):11318–30.
Wu C, Liu Y, Yang Y, Zhang P, Li X, Zheng M, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020.
Hofmann H, Po S. Cellular entry of the SARS coronavirus. TRENDS Microbiol. 2004; 12(10):466–472.
Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, Genome Organization , Replication , and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2. Med Virol from Pathog to Dis Control. 2020; 2:23–31.
Li F. Structure, Function and Evolution of Coronavirus Spike Proteins. Annu Rev ofVirology. 2016; 237–264.
Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2020; 1–10.
Cao Y, Deng Q, Dai S. Remdesivir for Severe Acute Respiratory Syndrome Coronavirus 2. Travel Med Infect Dis. 2020; 10:16-47.
Schoeman D, Fielding BC. Coronavirus envelope protein : current knowledge. Schoeman Feilding Virol J. 2019; 1–22.
Astuti DM ndwiani, Ysrafil, M.Biomed. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2): An Overview of Viral Structure and Host Response. Diabetes Metab Syndr Clin Res Rev. 2020; 2.
Zhavoronkov A, Aladinskiy V, Zhebrak A, Zagribelnyy B, Terentiev V, Dmitry S, et al. Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches. BMC. 2020 ;( 2).
Liu C, Zhou Q, Li Y, Garner L V, Watkins SP, Carter LJ, et al. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. Am Chem Soc. 2020; 6:315–31.
Mirza MU, Froeyen M. Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase. J Pharm Anal. 2020.
Hertzig T, Thiel V, Ivanov KA, Schelle B, Bayer S, Weißbrich B, et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol. 19 June 2003; 8:2305–15.
Zhang L, Lin D, Sun X, Curth U, Drosten C. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a -ketoamide inhibitors. April 2020;4(12): 409–412.
Al-tawfiq JA, Al-homoud AH, Memish ZA. Remdesivir as a possible therapeutic option for the COVID-19. Travel Med Infect Dis. 2020; 10-15.
Amirian ES, Levy JK. Current knowledge about the antivirals remdesivir (GS-5734) and GS- 441524 as therapeutic options for coronaviruses. One Heal. 9 March 2020;100128.
Choy K, Wong AY, Kaewpreedee P, Sia S. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020;104786.
To L, Editor THE. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV ) in vitro. January 2020; 19–21.
Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, et al. Coronavirus Susceptibility to the Antiviral Remdesivir ( GS- 5734 ) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. 1–15.
Brockway SM, Denison MR. Molecular targets for the rational design of drugs to inhibit SARS coronavirus. 2004;1(2):205–9.
Adedeji AO, Marchand B, Velthuis AJW, Snijder EJ, Weiss S, Eoff RL, et al. Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase. PLoS One. 2012; 7(5).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
